Labcorp and Lunit Collaborate to Advance AI-Powered Digital Pathology Research in Oncology
ByAinvest
Monday, Nov 17, 2025 9:09 am ET1min read
LH--
Lunit and Labcorp collaborate to advance AI-powered digital pathology research, leveraging Labcorp's clinical and pathology expertise and Lunit's AI algorithms to analyze tumor microenvironments. The collaboration aims to generate new insights that can enhance biomarker discovery and guide precision immuno-oncology strategies. The first outcome of the collaboration was showcased at two leading scientific conferences, demonstrating the predictive power of AI-based spatial profiling in MET-mutated non-small cell lung cancer.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet